Eli Lilly threatens to withhold 340B discounts from hospitals that don’t share claims data
Lilly told providers in January to submit claims data for all dispensed 340B drugs, claiming it’s a “lawful, modest integrity measure.” But the company only recently started suggesting it would enforce the policy by withholding discounts.
